Company Urologix, Inc.

Equities

ULGX

US9172731047

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 09:48:12 2024-03-08 am EST 5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Urologix, Inc. -.--% -.--%

Business Summary

21st North Inc. is not engaged in any operating activity. The Company has dissolved.

Number of employees: 61

Sales per Business

USD in Million2013Weight2014Weight Delta
Medical Products
100.0 %
17 100.0 % 14 100.0 % -14.20%

Sales per region

USD in Million2013Weight2014Weight Delta
United States
100.0 %
17 100.0 % 14 100.0 % -14.20%

Managers

Managers TitleAgeSince
Founder 63 91-05-28
Director of Finance/CFO 63 15-03-31
Sales & Marketing 51 11-06-15

Members of the board

Members of the board TitleAgeSince
Founder 63 91-05-28
Director/Board Member 74 05-09-30
Director/Board Member 57 10-08-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,817,726 21,817,726 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Merrill Lynch Investment Managers, Inc.
0.0284 %
6,200 0.0284 % - $
Whatifi Asset Management, Inc.
0.0165 %
3,600 0.0165 % - $
AW Advisors LLC
0.000917 %
200 0.000917 % - $

Company contact information

Urologix, Inc.

14405 21st Avenue North

55447-4699, Minneapolis

+

address Urologix, Inc.(ULGX)
  1. Stock Market
  2. Equities
  3. ULGX Stock
  4. Company Urologix, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW